See what questions
a doctor would ask.
HIV-1E: HIV is an immune system disease caused by the HIV virus. AIDS is a term used when a person infected with HIV has a CD4+ T cell count below 200 or 14% of lymphocytes. AIDS is an advanced form of HIV. To be classified as AIDS the person must also have an AIDS-related condition such as opportunistic infections. Once a person has been diagnosed with AIDS, even if treatment improved their CD4+ T cell count and infections are under control, the person is still considered to have AIDS. HIV is classified into two subtypes - HIV-1 and HIV-2. HIV-1 is further classified into three groups - Group M, N and O. Group M is further classified into 9 subgroups - A to K and CRFs. CRF's are circulating recombinant forms which are a combination of any two subtypes e.g. CRF A/C involves both And C subtypes. HIV-1, Group M, subtype E has to date not occurred on its own but has occurred in combination with subtype A in a subtype called CRF A/E. This subtype occurs mainly in Asia and originated in central Africa. It tends to be transmitted mainly through heterosexual contact i.e. infection occurs through mucosal exposure. More detailed information about the symptoms, causes, and treatments of HIV-1E is available below.
Home medical testing related to HIV-1E:
Review possible medical complications related to HIV-1E:
Read more about causes of HIV-1E.
Commonly undiagnosed diseases in related medical categories:
Research related physicians and medical specialists:
Other doctor, physician and specialist research services:
Research quality ratings and patient safety measures for medical facilities in specialties related to HIV-1E:
Choosing the Best Hospital: More general information, not necessarily in relation to HIV-1E, on hospital performance and surgical care quality:
Prognosis for HIV-1E: Death usually occurs between 6 and 19 months after diagnosis of AIDS if not treatment is utilized. Strict adherence to treatment plans (usually antiretroviral medications) can significantly improve long-term outcomes. A number of people will develop a resistance to treatment therapies if they have been on them for more than two decades.
Read about other experiences, ask a question about HIV-1E, or answer someone else's question, on our message boards:
Search Specialists by State and City